Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin‐resistance, invasion and stemness acquisition-Reference-Cited by-同舟云学术

Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin‐resistance, invasion and stemness acquisition

Published:2020-07-25 Issue:11 Volume:42 Page:3282-3294
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Kashyap Tanushree¹,Nath Nidhi¹,Mishra Prajna²,Jha Arpita¹,Nagini Siddavaram³,Mishra Rajakishore¹^ORCID

Affiliation:

1. Department of Life Sciences School of Natural Sciences, Central University of Jharkhand Ranchi Jharkhand India

2. Centre for Applied Chemistry School of Natural Sciences, Central University of Jharkhand Ranchi Jharkhand India

3. Department of Biochemistry and Biotechnology, Faculty of Science Annamalai University Annamalainagar Tamil Nadu India

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26373

Reference60 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression

3. Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression

4. The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance

5. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP14 promotes the cancer stem‐like cell properties of OSCC via promoting SOX2 deubiquitination;Oral Diseases;2024-02-20

2. Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies;Pathology - Research and Practice;2024-01

3. Therapeutic role of microRNAs in management of head and neck cancer;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

4. Recent Advances in the Targeting of Head and Neck Cancer Stem Cells;Applied Sciences;2023-12-15

5. Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance;International Immunopharmacology;2023-11